Literature DB >> 7844558

The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus.

S Becker1, M Spiess, H D Klenk.   

Abstract

The liver is one of the main target organs of Marburg virus (MBG), a filovirus causing severe haemorrhagic fever with a high fatality rate in humans and non-human primates. MBG grown in certain cells does not contain neuraminic acid, but has terminal galactose on its surface glycoprotein. This observation indicated that the asialoglycoprotein receptor (ASGP-R) of hepatocytes may serve as a receptor for MBG in the liver. Binding studies revealed that the attachment of MBG to ASGP-R-expressing HepG2 cells, but not to ASGP-R-negative E6 Vero cells, has the characteristics of ligand binding to the ASGP-R: binding is dependent on calcium and is inhibited by excess asialofetuin and by anti-ASGP-R antiserum. Asialofetuin and the specific antiserum also inhibited MBG infection of HepG2 cells. In addition, it was shown that expression of ASGP-R cDNA in NIH 3T3 cells enhanced the susceptibility of these cells to MBG infection 4.5-fold. Interaction of MBG with the hepatic ASGP-R could thus explain the marked hepatotropism of the virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7844558     DOI: 10.1099/0022-1317-76-2-393

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  58 in total

1.  Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells.

Authors:  C Sänger; E Mühlberger; E Ryabchikova; L Kolesnikova; H D Klenk; S Becker
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Membrane association induces a conformational change in the Ebola virus matrix protein.

Authors:  S Scianimanico; G Schoehn; J Timmins; R H Ruigrok; H D Klenk; W Weissenhorn
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

3.  Crystal structure of the matrix protein VP40 from Ebola virus.

Authors:  A Dessen; V Volchkov; O Dolnik; H D Klenk; W Weissenhorn
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

4.  DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.

Authors:  Andrea Marzi; Thomas Gramberg; Graham Simmons; Peggy Möller; Andrew J Rennekamp; Mandy Krumbiegel; Martina Geier; Jutta Eisemann; Nadine Turza; Bertrand Saunier; Alexander Steinkasserer; Stephan Becker; Paul Bates; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

6.  Multivesicular bodies as a platform for formation of the Marburg virus envelope.

Authors:  Larissa Kolesnikova; Beate Berghöfer; Sandra Bamberg; Stephan Becker
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP.

Authors:  Shuzo Urata; Takeshi Noda; Yoshihiro Kawaoka; Shigeru Morikawa; Hideyoshi Yokosawa; Jiro Yasuda
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

8.  Glyco-poly-l-lysine is better than liposomal delivery of exogenous genes to rat of liver.

Authors:  Chang-Qing Yang; Ji-Yao Wang; Bo-Ming He; Jian-Jun Liu; Jin-Sheng Guo
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

9.  The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection.

Authors:  Eva Mittler; Larissa Kolesnikova; Bettina Hartlieb; Robert Davey; Stephan Becker
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

Review 10.  Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.

Authors:  Jaleh Varshosaz; Maryam Farzan
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.